Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
32 Cards in this Set
- Front
- Back
lifetime prevelance of schizophrenia
|
1%
|
|
positive symptoms
|
-delusions (FIXED, false beliefs)
-hallucinations (auditory hallmark) |
|
negative symptoms
|
-blunted effect
-anhedonia -avolition -poverty of speech -poor hygiene |
|
nigrostriatal dopaminergic tract function (2)
|
1)EPS
2)movement |
|
mesolimbic function (4)
|
1)arousal
2)memory 3)stimulus processing 4)motivational behavior |
|
mesocortical function (4)
|
1)cognition
2)communication 3)social function 4)stress response |
|
tuberoinfundibular function (1)
|
1)regulates PL release
|
|
neurochemical alterations in the limbic system and mesocortical tract
|
mesolimbic system has increased DA, mesocortical tract has decreased DA
|
|
positive symptoms are thought to come from which dopaminergic tract?
|
2-mesolimbic
|
|
negative symptoms are thought to come from which dopaminergic tract?
|
3-mesocortical
|
|
dystonia definition
|
sustained muscle contraction
|
|
onset of dystonia
|
1-4d after dose administration or dose increase
|
|
dystonia risk factors
|
young males, high potency APs
|
|
akathisia definition
|
subjective feeling of motor restlessness
|
|
akathisia objective signs
|
-pacing
-tapping feet -inability to sit still |
|
akathisia onset
|
days to weeks
|
|
akathisia occurence
|
20-40% of pts treated w/ high potency agents
|
|
list the four cardinal symptoms of pseudoparkinsonism
|
1)akinesia, bradykinesia, bradyphrenia
2)resting tremor 3)cogwheel rigidity 4)postural abnormalities |
|
pseudoparkinsonism onset
|
1-2wks after initiation of therapy or dose increase
|
|
pseudoparkinsonism risk factors
|
-female
-age >40 -high potency APs |
|
tardive dyskinesia definition
|
abnormal involuntary movements
(chewing/lip smacking, foot tapping, toe movement, tics, grimaces, blinking, tongue thrusting) |
|
movements tend to increase when a patient is _____ and disappear during _____
|
aroused; sleep
|
|
tardive dyskinesia onset
|
insidious, occurs w/ chronic treatment
|
|
tardive dyskniesia risk factors
|
-increasing age
-acute EPS -poor AP response -organic mental d/o -diabetes -mood d/o -females |
|
key to tardive dyskinesia
|
prevention since it is often irreversible
|
|
neuroleptic malignant syndrome characterization
|
-hyperpyrexia
-altered MS -tachycardia -fluctuating BP -sweating -urinary, fecal incontinence -rigidity |
|
abnormal labs that are common with neuroleptic malignant syndrome
|
elevated CPK, LFTs
|
|
risk factors for neuroleptic malignant syndrome
|
pts receiving high potency, injectible, or depot APs
|
|
neuroleptic malignant syndrome onset
|
ranges from initial treatment to several months after initial treatment
|
|
effect of APs on ECG
|
-APs can produce direct myocardial depression, and can antagonize sympathetic nervous system activity
-ECG changes include tachycardia, flattened T waves, ST segment depression, and prolongation of QT and PR intervals |
|
normal prolactin concentration
|
1.4ng/mL-26.7ng/mL
|
|
elevated PL levels may lead to what? (5)
|
1)amenorrhea
2)galactorrhea 3)gynecomastia 4)sexual dysfunction 5)osteoporosis |